cn3
Thursday 21 December 2017
Alzheimer's Setback Is Warning to Biogen Investors
Biogen’s stumble in Alzheimer’s disease should remind investors of bigger risks in the future.
from WSJ.com: Markets http://ift.tt/2BXJaNl
via https://ifttt.com/ IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment